Algert Global LLC bought a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 39,284 shares of the financial services provider’s stock, valued at approximately $3,240,000.
A number of other institutional investors have also recently modified their holdings of MET. Kingsview Wealth Management LLC grew its holdings in MetLife by 14.8% in the third quarter. Kingsview Wealth Management LLC now owns 3,899 shares of the financial services provider’s stock valued at $322,000 after purchasing an additional 502 shares during the period. Cerity Partners LLC grew its stake in MetLife by 64.3% in the 3rd quarter. Cerity Partners LLC now owns 69,689 shares of the financial services provider’s stock valued at $5,748,000 after acquiring an additional 27,274 shares during the period. Great Valley Advisor Group Inc. increased its holdings in MetLife by 1.3% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider’s stock worth $781,000 after acquiring an additional 123 shares in the last quarter. Nicolet Advisory Services LLC lifted its holdings in MetLife by 6.0% during the third quarter. Nicolet Advisory Services LLC now owns 6,927 shares of the financial services provider’s stock valued at $563,000 after purchasing an additional 393 shares in the last quarter. Finally, Eagle Asset Management Inc. purchased a new stake in shares of MetLife during the third quarter worth about $8,643,000. 89.81% of the stock is currently owned by institutional investors and hedge funds.
MetLife Trading Up 0.9 %
Shares of NYSE MET opened at $87.36 on Tuesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $60.49 billion, a PE ratio of 17.61, a PEG ratio of 0.79 and a beta of 1.05. MetLife, Inc. has a twelve month low of $62.81 and a twelve month high of $87.64. The stock has a fifty day simple moving average of $82.68 and a 200-day simple moving average of $76.18.
MetLife Announces Dividend
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on MET shares. TD Cowen started coverage on MetLife in a report on Wednesday, October 9th. They issued a “buy” rating and a $97.00 price objective on the stock. Jefferies Financial Group increased their price objective on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. Piper Sandler upped their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Barclays dropped their price objective on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. Finally, StockNews.com upgraded MetLife from a “hold” rating to a “buy” rating in a report on Monday. Fourteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $88.46.
Get Our Latest Research Report on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- 3 Stocks to Consider Buying in October
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Stock Average Calculator
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- How to Most Effectively Use the MarketBeat Earnings Screener
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.